News

Advent Eyes New Mid-Market Strategy for Smaller Deals

(Bloomberg) -- Buyout firm Advent is contemplating setting up an investment vehicle targeting mid-sized transactions as it looks to bolster its core private equity business.Most Read from BloombergRiyadh Metro Partially Opens in Bid to Ease City’s Traffic JamsAs Wars Rage, Cities Face a Dark New Era of Urban DestructionAdvent, which is focused on buying controlling stakes in businesses, raised $25 billion for its flagship buyout fund in 2022 — its largest fundraising to date. The firm sees a “fi

Why Is Purple Biotech Stock Trading Higher On Monday?

On Monday, Purple Biotech Ltd (NASDAQ:PPBT) reported the final results from the randomized Phase 2 study of its lead oncology drug, CM24, a humanized monoclonal antibody that blocks CEACAM1, in patients with pancreatic ductal adenocarcinoma (PDAC). Purple Biotech stock is trading higher with a strong session volume of 9.7 million, compared to an average volume of 48.73K as per data from Benzinga Pro. The Phase 2 study evaluated CM24 in combination with Bristol Myers Squibb & Co’s (NYSE:BMY) immu

Bitcoin Can Run Another 95% Over the Next 18 Months, According to 2 Wall Street Analysts (Hint: Not MicroStrategy's Michael Saylor)

Bitcoin (CRYPTO: BTC), the world's largest cryptocurrency, has been on an astounding run since President-elect Donald Trump won the election on Nov. 5. While Bitcoin can be volatile and is tough to value given that it has no intrinsic value, some think the party might just be getting started and that Bitcoin will soon blow through $100,000 and surge much higher over the next 18 months. While most Bitcoin followers have heard MicroStrategy's Michael Saylor make the bold call that Bitcoin will hit $13 million in about two decades, this latest call is not from the billionaire but from two analysts at a respected Wall Street firm.